The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination Therapy
Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is associated with substantial morbidity and mortality. Vancomycin (VAN) has been used as the gold standard treatment for invasive MRSA infections for decades but, unfortunately, the reliance of VAN as the primary treatment option...
Saved in:
Main Authors: | Taylor Morrisette (Author), Sara Alosaimy (Author), Jacinda C. Abdul-Mutakabbir (Author), Razieh Kebriaei (Author), Michael J. Rybak (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2020) -
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant <i>Enterococcus</i> <i>faecium</i> and <i>faecalis</i>
by: Katie E. Barber, et al.
Published: (2021) -
Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant <i>Enterococcus faecium</i> with Preserved Phage Susceptibility
by: Ashlan J. Kunz Coyne, et al.
Published: (2022) -
Acute MRSA Sinusitis with Intracranial Extension and Marginal Vancomycin Susceptibility
by: Parvathi S. Kumar, et al.
Published: (2013) -
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
by: Cui Longzhu, et al.
Published: (2007)